February 17, 2005 | Part Of Safety of Arthritis Drugs, Day 2,

Safety of Arthritis Drugs, Day 2, Part 1

Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drug Arcoxia and for the Food and Drug Administration… read more

Physicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drug Arcoxia and for the Food and Drug Administration spoke about a number of issues including initial testing of the class of drugs, the review process at the FDA, and the medical issues in question. They also responded to questions from members of the committee.

A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the advisory committee was to provide advice and recommendations to the FDA on regulatory issues. close

Report Video Issue

People in this video

Steven Abramson Chair New York University Medical School->Rheumatology
Joan Bathon Professor Johns Hopkins University School of Medicine

Dennis Boulware Professor University of Alabama at Birmingham->Medicine
Byron Cryer M.D. Professor University of Texas at Dallas->Southwestern Medical School
Ralph D'Agostino Professor Boston University->Public Health and Statistics
Ruth Day Senior Fellow Duke University->Aging Center
John Farrar Director University of Pennsylvania->Clinical Epidemiology and Biostatistics
Thomas Fleming Chairman University of Washington->Biostatistics
Lawrence Friedman Official National Institutes of Health
Allan Gibofsky Chairman U.S. Food and Drug Administration->Arthritis Advisory Cmte.
David Graham Medical Officer U.S. Food and Drug Administration->Pharmaceutical Science
Charles Hennekens Professor University of Miami->School of Medicine
Louis Morris President Louis A. Morris and Associates
Steven E. Nissen M.D. Medical Director Cleveland Clinic Foundation->Cardiovascular Coord. Ctr.
Robert O'Neil Director U.S. Food and Drug Administration->Biostatistics
Richard Platt Professor Harvard University->Medical School
Steven Schafer Professor Stanford University->School of Medicine
Annette Stemhagen Official Covance Periapproval Services
Robert Temple Director U.S. Food and Drug Administration->Office of Drug Evaluation
Kimberly Topper Executive Secretary U.S. Food and Drug Administration->Center for Drug Evaluation and Research
Alastair J. J. Wood M.D. Chairman U.S. Food and Drug Administration->Arthritis Advisory Cmte.

More People

Hosting Organization

U.S. Food and Drug AdministrationU.S. Food and Drug Administration

More Videos From

Safety of Arthritis Drugs, Day 2,

130 Views

Program ID:: 185588-1
Category:: Public Affairs Event
Format:: Forum
Location:: Gaithersburg, Maryland, United States
First Aired:: Feb 18, 2005 | 5:39am EST | C-SPAN 2
Last Aired:: Feb 24, 2005 | 9:30am EST | C-SPAN 2

Airing Details

Feb 18, 2005 | 5:39am EST | C-SPAN 2
Feb 18, 2005 | 11:48am EST | C-SPAN 2
Feb 24, 2005 | 9:30am EST | C-SPAN 2

MP3 audio - Standard

Price:

$0.99

Request Download
Alert me when this program is available for purchase.
- Name
- Email
Error requesting format availability.

Your request has been submitted.
There was an error processing your purchase.

Related Video

See all on Research Drugs (Pharmaceuticals) Research

February 19, 2008
FDA Oversight

Anna Edney talked about the responsibilities of the Food and Drug Administration (FDA) and the role of Congressional…
July 31, 2008
FDA Oversight of Food Safety

Representative Timothy Murphy talked about today’s House Energy and Commerce hearing on the Salmonella outbreak, and he…
July 21, 2010
FDA Drug Approval Process

Catherine Larkin talked about the FDA’s drug approval and review processes for current drugs on the market. She…
September 19, 2011
Safety of Foreign-Made Prescription Drugs

Allan Coukell talked about the Governmental Accountability Office (GAO) report on the make-up of prescription drugs,…